logo

For the Inventor, By the Inventor

Tucson, AZ, United States of America

Kirsten Bjergarde

This inventor holds 6 USPTO granted patents and 5 published patent applications and 5 EPO patents. Top assignees: Sanofi-Aventis, Aventis Pharma S.a., Sanofi. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kirsten Bjergarde. Retrieved from https://idiyas.com/inventor/kirsten-bjergarde

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 33.3

 

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Tucson, AZ (US) (2011 - 2012)
  • Tuscon, AZ (US) (2013)

Company Filing History:

goldMedal3 out of 390 
 
Sanofi-Aventis
 patents
silverMedal2 out of 377 
 
Aventis Pharma S.a.
 patents
bronzeMedal1 out of 1,546 
 
Sanofi
 patents

Years Active: 2011-2013

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 8420824 - Substituted pyrazoles, compositions containing these, method of production and use (2013-04-16),
2. 8410286 - Substituted pyrazoles, compositions containing these, method of production and use (2013-04-02),
3. 8163768 - 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them (2012-04-24),
4. 8058290 - 7-substituted aza-indazoles, compositions containing same, production method and use thereof (2011-11-15),
5. 7989439 - Substituted pyrazoles, compositions containing these, method of production and use (2011-08-02),
6. 7910602 - Pyrazolopyridine derivatives as inhibitors of β-Adrenergic receptor kinase 1 (2011-03-22),

Title: Kirsten Bjergarde: Innovator in Pharmaceutical Chemistry

Introduction

Kirsten Bjergarde is a prominent inventor based in Tucson, AZ (US), known for her significant contributions to pharmaceutical chemistry. With a total of six patents to her name, she has made remarkable strides in the development of innovative compounds.

Latest Patents

Her latest patents focus on substituted pyrazoles, which include compositions containing these compounds, methods of production, and their use, particularly as drugs. The disclosures relate to a compound of formula (I) and salts thereof, wherein various components are defined in the disclosure. These advancements highlight her commitment to enhancing drug development and therapeutic applications.

Career Highlights

Throughout her career, Kirsten has worked with notable companies such as Sanofi-Aventis and Aventis Pharma S.A. Her experience in these leading pharmaceutical firms has allowed her to refine her expertise and contribute to groundbreaking research in the field.

Collaborations

Kirsten has collaborated with esteemed colleagues, including Anil Nair and Marcel Patek, further enriching her professional journey and expanding her impact in the industry.

Conclusion

Kirsten Bjergarde's innovative work in pharmaceutical chemistry and her dedication to advancing drug development through her patents make her a noteworthy figure in the field. Her contributions continue to influence the landscape of pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…